BIOLUX P-III SPAIN All-Comers Registry

NCT03052296 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2021-08-05

No results posted yet for this study

Summary

The purpose of the BIOLUX P-III Spain registry is to further investigate the safety and clinical performance of the Passeo-18 Lux Drug Coated Balloon in the treatment of long atherosclerotic femoropoliteal artery lesions in daily clinical practice

Conditions

  • Peripheral Arterial Disease

Interventions

DEVICE

Passeo-18 Lux DCB

The endovascular procedure is conducted as per the local standard practice and device instruction for use

Sponsors & Collaborators

  • Biotronik AG

    lead INDUSTRY

Principal Investigators

  • Miguel Angel de Gregorio · Hospital Clínico and University of Zaragoza

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-22
Primary Completion
2019-11-05
Completion
2019-11-05

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03052296 on ClinicalTrials.gov